PUBLICACIONES
Bibliografía reciente
de interés
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. Peyvandi
F, Scully M, Kremer Hovinga JA, Cataland S, Knöbl P, Wu H, et al; TITAN
Investigators. N Engl J Med. 2016 Feb 11;374(6):511-22.
Blombery P, Kivivali L, Pepperell D, McQuilten Z, Engelbrecht S,
Polizzotto Mnet al; TTP registry steering committee. Diagnosis and management
of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the
first five years of the Australian TTP/Thrombotic Microangiopathy registry.
Intern Med J. 2015 Oct 19. doi: 10.1111/imj.12935. [Epub ahead of
print] http://www.ncbi.nlm.nih.gov/pubmed/26477687
Tersteeg C, Verhenne S, Roose E, Schelpe AS, Deckmyn H, De Meyer SF et
al. ADAMTS13 and anti-ADAMTS13 autoantibodies inthrombotic
thrombocytopenic purpura- current perspectives and new treatment
strategies. Expert Rev Hematol. 2015 Nov 18. [Epub ahead of
print] http://www.ncbi.nlm.nih.gov/pubmed/26581428
Toussaint-Hacquard M, Coppo P, Soudant M, Chevreux L, Mathieu-Nafissi S,
Lecompte Tet al. Type of plasma preparation used for plasma exchange and
clinical outcome of adult patients with acquired idiopathic thrombotic
thrombocytopenic purpura: a French retrospective multicenter cohort study.
Transfusion. 2015
Oct;55(10):2445-51. http://www.ncbi.nlm.nih.gov/pubmed/26173755
Delmas Y, Helou S, Chabanier P, Ryman A, Pelluard F, Carles D, et al.
Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective
study within thrombocytopenic pregnant women. A difficult diagnosis and a
treatable disease. BMC Pregnancy Childbirth. 2015 Jun
17;15:137. http://www.ncbi.nlm.nih.gov/pubmed/26081109
Bittencourt CE, Ha JP, Maitta RW. Re-examination of 30-day survival and
relapse rates in patients with thrombotic thrombocytopenic purpura-hemolytic
uremic syndrome. PLoS One. 2015 May
22;10(5):e0127744.http://www.ncbi.nlm.nih.gov/pubmed/26000799
Gavriilaki E, Yuan X, Ye Z, Ambinder AJ, Shanbhag SP, Streiff MB et al.
Modified Ham test for atypical hemolytic uremic syndrome. Blood. 2015 Jun
4;125(23):3637-46http://www.ncbi.nlm.nih.gov/pubmed/25862562
Pérez-Rodríguez
A, Lourés E, Rodríguez-Trillo Á, Costa-Pinto J, García-Rivero A, Batlle-López A
et al. Inherited ADAMTS13 deficiency (Upshaw-Schulman
syndrome): a short review. Thromb Res. 2014
Dec;134(6):1171-5. http://www.ncbi.nlm.nih.gov/pubmed/25242241
Artículos publicados por
el Grupo de Estudio de la PTT.
Julio del
Río-Garma, Javier de la Rubia, Iñigo Romón, José Antonio García-Erce, Enric
Contreras, Cristina Arbona and Arturo Pereira. RE: Type of
virus-securized plasma an treatment refractoriness in thrombotic
thrombocytopenic purpura . [e-Letter], Blood.
(http://www.bloodjournal.org/content/125/25/3860.e-letters). 2 September 2015. Accessed
3 September 2015
Julio del Río ,
Arturo Pereira , Javier de la Rubia , José Antonio García-Erce , Cristina
Arbona , Enric Contreras and Miguel Lozano. RE: Platelet
transfusion as a proxy for more severe thrombotic thrombocytopenic
purpura. [e-Letter], Blood.
(http://www.bloodjournal.org/content/125/9/1470.e-letters). 13 March 13 2015. Accessed
March 25, 2015
Contreras E, de
la Rubia J, Del Río-Garma J, Díaz-Ricart M, García-Gala JM, Lozano M; por el
Grupo Español de Aféresis. Guía diagnóstica y terapéutica de las
microangiopatías trombóticas del Grupo Español de Aféresis. Med
Clin (Barc). 2015 Apr
8;144(7):331 http://www.ncbi.nlm.nih.gov/pubmed/25433791
De la Rubia J,
Contreras E, del Río-Garma J. Púrpura trombótica trombocitopenica. Med
Clin (Barc) 2011; 136(12)
:534-540. http://www.ncbi.nlm.nih.gov/pubmed/25433791
de la Rubia J, Moscardó
F, Gómez MJ, Guardia R, Rodríguez P, Sebrango A, et al. Efficacy
and safety of rituximab in adult patients with idiopathic relapsing or
refractory thrombotic thrombocytopenic purpura: results of a Spanish
multicenter study. Transfus Apher Sci 2010;43:299-303. http://www.ncbi.nlm.nih.gov/pubmed/20934383
Álvarez-Larrán
A, Río-Garma J, Pujol M, de la Rubia J, Hernández-Jodrá M, Borrell M, et
al. Newly diagnosed versus relapsed idiopathic thrombotic
thrombocytopenic purpura: a comparison of presenting clinical characteristics
and response to treatment. Ann Hematol
2009;88:973-8. http://www.ncbi.nlm.nih.gov/pubmed/19205654
Río-Garma J,
Álvarez-Larrán A, Martínez C, Muncunill J, Castellà D, de la Rubia J, et
al. Methylene blue-photoinactivated plasma versus
quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a
multicentric, prospective cohort study. Br J Haematol
2008;143:39-45. http://www.ncbi.nlm.nih.gov/pubmed/18637799
Río-Garma J, Pereira A, Arroyo JL, Mateo J, Álvarez-Larrán A, Martínez
C, Muncunill J, Barbolla L. ADAMTS-13 activity and von Willebrand factor levels
in methylene-blue photo-inactivated plasma processed by either the Springe
method or an ´in house´ system. Vox Sang
2008;95:101-5. http://www.ncbi.nlm.nih.gov/pubmed/18557825
Pereira A. Efficacy of different plasma sources in the treatment of
thrombotic thrombocytopenic purpura. ISBT Science Series 2009; 4(1): 111-117.
Muncunill J. Thrombotic thrombocytopenic purpura (TTP): Is any plasma useful to treat the TTP?. ISBT Science Series 2007; 2(1): 233-239.
Guías Clínicas
Contreras
E, de la Rubia J, Del Río-Garma J, Díaz-Ricart M, García-Gala JM, Lozano M; por el
Grupo Español de Aféresis. Guía diagnóstica y
terapéutica de las microangiopatías trombóticas. Med Clin (Barc). 2015
Apr 8;144(7):331; http://www.ncbi.nlm.nih.gov/pubmed/25433791
Scully M, Hunt BJ, Benjamin
S, Liesner R, Rose P, Peyvandi F, et al; British Committee for Standards in
Haematology.
Publicaciones sobre PTT y
MAT realizadas por los miembros del GEPTT antes / después de la constitución
formal y por otros autores españoles.
Gainza E,
Fernández S, Martínez D, Castro P, Bosch X, Ramírez Jet al. Pulmonary
tumor thrombotic microangiopathy: report of 3 cases and review of the
literature. Medicine
(Baltimore). 2014 Nov;93(24):359-63. http://www.ncbi.nlm.nih.gov/pubmed/25500705
Pérez-Rodríguez
A, Lourés E, Rodríguez-Trillo Á, Costa-Pinto J, García-Rivero A, Batlle-López A
et al. Inherited ADAMTS13 deficiency (Upshaw-Schulman
syndrome): a short review. Thromb Res. 2014
Dec;134(6):1171-5. http://www.ncbi.nlm.nih.gov/pubmed/25242241
Pérez-Rodríguez
A, Batlle-López A, Blanco R, Varela I, León J, Delgado MD et al. A
novel mutation in ADAMTS13 of a child with Upshaw-Schulman Syndrome. Thromb
Haemost. 2014 Nov;112(5):1065-8.http://www.ncbi.nlm.nih.gov/pubmed/25057114
Quintero V, Garcia-Pose A, Barrios-Tascon A, Pacheco-Cumani M.
Congenital ADAMTS13 deficiency: a rare mimicker of immune thrombocytopenic
purpura. J Pediatr Hematol Oncol. 2014
Nov;36(8):653-5.http://www.ncbi.nlm.nih.gov/pubmed/24942015
González-Mesa E, Narbona I, Blasco M, Cohen I. Unfavorable course in
pregnancy-associated thrombotic thrombocytopenic purpura necessitating a
perimortem Cesarean section: a case report. J Med Case Rep. 2013 Apr
29;7:119. http://www.ncbi.nlm.nih.gov/pubmed/23628258
Verdú J,
Fernández P, Rivas C, Romero A, Soler S, Verdú JJ. Características
clínico-biológicas de las púrpuras trombocitopénicas trombóticas tratadas entre
los años 1983-2006 en el Hospital General Universitario de Alicante. Rev
Clin Esp 2007 May;207(5):243-5. http://www.ncbi.nlm.nih.gov/pubmed/17504669
Alvarez-Larrán A, Del Río J, Ramírez C, Albo C, Peña F, Campos A, Cid J,
Muncunill J, Sastre JL, Sanz C. Pereira A. Methylene blue-photoinactivated
plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in
thrombotic thrombocytopenic purpura. Vox Sanguinis 2004; 86:
246-251. http://www.ncbi.nlm.nih.gov/pubmed/15144529
Castellá D, Pujol M, Juliá A, Massague I, Bueno J, Ramón Grifols J, Puig
L. Thrombotic thrombocytopenic purpura and pregnancy: a review of ten cases.
Vox Sang 2004; 87(4):287-90.http://www.ncbi.nlm.nih.gov/pubmed/15585025
Lozano M, Domingo A, Pereira A, Fontanals J, Mazzara R. Platelet
transfusion in thrombotic thrombocytopenic purpura: between Scylla and
Charybdis. Transfusion. 2005 Dec;45(12):1984.http://www.ncbi.nlm.nih.gov/pubmed/16371055
Alvarez-Larrán A, Petriz J, Martínez A, Sanz C, Pereira A. Plasma from
patients with thrombotic thrombocytopenic purpura induces activation of human
monocytes and polymorphonuclear neutrophils. Br J Haematol 2003;
120(1):129-34. http://www.ncbi.nlm.nih.gov/pubmed/12492588
de la Rubia J,
Plumé G, Arriaga F, Carpio N, Sanz MA, Marty ML. Platelet
transfusion and thrombotic thrombocytopenic purpura. Transfusion 2002
Oct;42(10):1384-5. http://www.ncbi.nlm.nih.gov/pubmed/12423525
de la Rubia J,
Arriaga F, Linares D, Larrea L, Carpio N, Marty ML, Sanz MA. Role
of methylene blue-treated or fresh-frozen plasma in the response to plasma
exchange in patients with thrombotic thrombocytopenic purpura. Br J Haematol 2001;
114:721-723. http://www.ncbi.nlm.nih.gov/pubmed/11553005
de la Rubia J,
García I, Jarque I, Arriaga F, Gomis F, Sanz MA. Splenectomy in
patients with refractory or relapsing thrombotic thrombocytopenic
purpura. Haematologica
2000 Apr;85(4):440-1.http://www.ncbi.nlm.nih.gov/pubmed/10756380
de la Rubia J,
López A, Arriaga F, Cid AR, Vicente AI, Marty ML, Sanz MA. Response
to plasma exchange and steroids as combined therapy for patients with
thrombotic thrombocytopenic purpura. Acta Haematol 1999;102(1):12-6. http://www.ncbi.nlm.nih.gov/pubmed/10473882
Blanco A,
Palacio C, López A, Acebedo G, Castellá D, Juliá A. Púrpura trombótica
trombocitopénica. Estudio restrospectivo de 22 episodios consecutivos en 16
pacientes Med Clin (Barc) 1998; 111(10):385-8.http://www.ncbi.nlm.nih.gov/pubmed/9833242
Pereira A, Mazzara R, Monteagudo J, Sanz C, Puig L, Martínez A, Ordinas
A, Castillo R. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a
multivariate analysis of factors predicting the response to plasma exchange.
Ann Hematol 1995; 70(6):319-23. http://www.ncbi.nlm.nih.gov/pubmed/7632812
Pereira A, Monteagudo J, Bono A, Lopez-Guillermo A, Ordinas A. Effect of
splenectomy on von Willebrand factor multimeric structure in thrombotic
thrombocytopenic purpura refractory to plasma exchange. Blood Coagul
Fibrinolysis. 1993;4(5):783-6. http://www.ncbi.nlm.nih.gov/pubmed/8292728
Monteagudo J, Pereira A, Reverter JC, Pijoan J, Tusell J, Puig L,
Ordinas A, Castillo R. Thrombin generation and fibrinolysis in the thrombotic
thrombocytopenic purpura and the hemolytic-uremic syndrome. Thromb Haemost
1991;66(5):515-9. http://www.ncbi.nlm.nih.gov/pubmed/1803613
Monteagudo J, Pereira A, Roig S, Reverter JC, Ordinas A, Castillo R.
Investigation of plasma von Willebrand factor and circulating platelet
aggregating activity in mitomycin C-related hemolytic-uremic syndrome. Am J
Hematol 1990 Jan;33(1):46-9. http://www.ncbi.nlm.nih.gov/pubmed/2104558
Pereira A,
Mazzara R, Sanz C, Monteagudo J, Puig L, Castillo R.. Síndromes trombóticos
microangiopáticos del adulto: resultados del tratamiento con recambio
plasmático. Med Clin (Barc) 1990;
95(4):133-6.http://www.ncbi.nlm.nih.gov/pubmed/2250532